Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Relative Risk01:12

Relative Risk

123
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
123
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

124
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
124
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

2.5K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.5K
Hazard Ratio01:12

Hazard Ratio

92
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
92
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

1.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Hazard Rate01:11

Hazard Rate

92
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
92

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Reducing Risk Misinformation and Miscommunication: A Sheaf-Theoretic Perspective.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Necessary conditions for valid causal inference from observational data.

Critical reviews in toxicology·2026
Same author

Integrating Fragmented Risk Knowledge: Sheaf Theory for Risk Analysts.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Combining Diverse Expert Opinions in Risk Analysis Using Relative Causal Knowledge.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Improving the design of epidemiology studies that use biomonitoring for exposure assessment: a SciPinion panel recommendation.

BMC medical research methodology·2026
Same author

Living with risk, then and now: A dual review of Cam Grey's Living with Risk in the Late Roman World and of current AI-assisted book reviewing.

Risk analysis : an official publication of the Society for Risk Analysis·2025

相关实验视频

Updated: Jun 13, 2025

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K

计算可预防的风险分数,用于减少暴露的干预措施.

Louis Anthony Cox1

  • 1Cox Associates, Entanglement, University of Colorado, Denver, CO, USA.

Global epidemiology
|June 11, 2025
PubMed
概括

这项研究引入了新的因果指标,如可预防风险分数 (PRF) 曲线,以量化降低环境和职业暴露的风险降低程度. 这些工具为更好的风险评估和政策提供了科学严格的个人级预测.

科学领域:

  • 环境健康 环境健康
  • 流行病学 流行病学
  • 因果推理因果推理

背景情况:

  • 像人口归因分数 (PAFs) 这样的传统指标对干预因果问题有局限性.
  • 滥用基于关联的指标可能会导致不准确的风险评估.

研究的目的:

  • 引入新的因果指标,以量化环境和职业暴露的可预防风险分数.
  • 为基于机理因果关系的场景特定的个人级风险降低预测提供工具.

主要方法:

  • 介绍因果关系的干预概率 (IPoC),因果分配股份 (CAS) 和可预防风险分数 (PRF) 曲线.
  • 方法应用于案例研究:和AML,吸烟和肺癌,血和死亡率.
  • 使用蒙特卡洛模拟来进行个人间的变化和情景分析来确定实际的值.

主要成果:

  • PRF曲线有效量化了个人和人口层面减少暴露的风险降低效益.
  • 证明了处理风险暴露关系中的不确定性和异质性的能力.
  • 确定了进一步减少风险的门,从而产生日益减少的回报.

结论:

  • 拟议的因果关系框架将重点从归因转移到预防伤害.
关键词:
烯是一种烯.因果贝叶斯网络是因果贝叶斯网络.原因分析 原因分析流行病学 流行病学因果关系的干预概率.可避免的风险分数.风险评估 风险评估 风险评估

更多相关视频

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

相关实验视频

Last Updated: Jun 13, 2025

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging
08:30

X-ray Dose Reduction through Adaptive Exposure in Fluoroscopic Imaging

Published on: September 11, 2011

14.4K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
  • 为基于证据的风险评估,政策制定和法律决策提供透明,严格的方法.
  • 能够量化因果关系有效的干预措施和降低风险的好处.